Efficacy and safety of Paxlovid in severe adult patients with SARS-Cov-2 infection: a multicenter randomized controlled study
Liu et al., The Lancent Regional Health, doi:10.1016/j.lanwpc.2023.100694
https://c19early.org/liu6.html